Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
8.00
-1.12 (-12.28%)
Jun 2, 2026, 4:00 PM EDT - Market closed
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $9.33 million as of June 2, 2026. Its market cap has decreased by -33.21% in one year.
Market Cap
9.33M
Enterprise Value
542.66K
1-Year Change
-33.21%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $9.33M, a decrease of -95.27%. That is a compound annual growth rate of -44.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 9.33M | -0.93% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 11.63M |
| Jupiter Neurosciences | 11.39M |
| BioVie | 11.24M |
| Immuron | 10.98M |
| Kairos Pharma | 10.58M |
| BiomX | 10.55M |
| BioCardia | 10.46M |
| BioRestorative Therapies | 10.35M |